BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30365455)

  • 41. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.
    Laliscia C; Cosio S; Morganti R; Mazzotti V; Fabrini MG; Paiar F; Gadducci A
    Oncology; 2019; 96(5):235-241. PubMed ID: 30904907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
    Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
    Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Aggressive Surveillance for Locoregional Endometrial Cancer After Local Therapy.
    Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
    Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
    Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas.
    Kumar A; Le N; Gilks CB; Santos JL; Wong F; Swenerton K; Hoskins PJ; McAlpine JN; Tinker AV
    Int J Gynecol Cancer; 2017 Nov; 27(9):1819-1825. PubMed ID: 28930809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.
    Desai NB; Kiess AP; Kollmeier MA; Abu-Rustum NR; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Dec; 131(3):604-8. PubMed ID: 24055615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging.
    Vardi JR; Tadros GH; Anselmo MT; Rafla SD
    Obstet Gynecol; 1992 Aug; 80(2):204-8. PubMed ID: 1635733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: morbidity and survival.
    Magrina JF; Mutone NF; Weaver AL; Magtibay PM; Fowler RS; Cornella JL
    Am J Obstet Gynecol; 1999 Aug; 181(2):376-81. PubMed ID: 10454686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
    Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.
    Lan C; Huang X; Cao X; Huang H; Feng Y; Huang Y; Liu J
    Expert Opin Pharmacother; 2013 Apr; 14(5):535-42. PubMed ID: 23480059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative adjuvant chemotherapy in surgically staged grade 3 endometrial cancer.
    Takeshima N; Ota T; Omatsu K; Hasumi K; Takizawa K
    Anticancer Res; 2008; 28(3B):1785-8. PubMed ID: 18630460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
    Young MR; Higgins SA; Ratner E; Yu JB; Mani S; Silasi DA; Azodi M; Rutherford T; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ; Chu C; Rubin S; Lin LL
    Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.